These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 28386107)

  • 1. Constitutively active ABL family kinases, TEL/ABL and TEL/ARG, harbor distinct leukemogenic activities in vivo.
    Yokota A; Hirai H; Shoji T; Maekawa T; Okuda K
    Leukemia; 2017 Dec; 31(12):2742-2751. PubMed ID: 28386107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Tel-Abl (ETV6-Abl) tyrosine kinase, product of complex (9;12) translocations in human leukemia, induces distinct myeloproliferative disease in mice.
    Million RP; Aster J; Gilliland DG; Van Etten RA
    Blood; 2002 Jun; 99(12):4568-77. PubMed ID: 12036890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The leukaemic oncoproteins Bcr-Abl and Tel-Abl (ETV6/Abl) have altered substrate preferences and activate similar intracellular signalling pathways.
    Voss J; Posern G; Hannemann JR; Wiedemann LM; Turhan AG; Poirel H; Bernard OA; Adermann K; Kardinal C; Feller SM
    Oncogene; 2000 Mar; 19(13):1684-90. PubMed ID: 10763825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A direct binding site for Grb2 contributes to transformation and leukemogenesis by the Tel-Abl (ETV6-Abl) tyrosine kinase.
    Million RP; Harakawa N; Roumiantsev S; Varticovski L; Van Etten RA
    Mol Cell Biol; 2004 Jun; 24(11):4685-95. PubMed ID: 15143164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia.
    Golub TR; Goga A; Barker GF; Afar DE; McLaughlin J; Bohlander SK; Rowley JD; Witte ON; Gilliland DG
    Mol Cell Biol; 1996 Aug; 16(8):4107-16. PubMed ID: 8754809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells.
    Lacronique V; Boureux A; Monni R; Dumon S; Mauchauffé M; Mayeux P; Gouilleux F; Berger R; Gisselbrecht S; Ghysdael J; Bernard OA
    Blood; 2000 Mar; 95(6):2076-83. PubMed ID: 10706877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the NF-kappaB pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKKalpha.
    Malinge S; Monni R; Bernard O; Penard-Lacronique V
    Oncogene; 2006 Jun; 25(25):3589-97. PubMed ID: 16434962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MN1-TEL, the product of the t(12;22) in human myeloid leukemia, immortalizes murine myeloid cells and causes myeloid malignancy in mice.
    Carella C; Bonten J; Rehg J; Grosveld GC
    Leukemia; 2006 Sep; 20(9):1582-92. PubMed ID: 16810199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of chimeric Gag-Arg/Abl molecules indicates a distinct negative regulatory role for the Arg C-terminal domain.
    Mysliwiec T; Perego R; Kruh GD
    Oncogene; 1996 Feb; 12(3):631-40. PubMed ID: 8637720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new ETV6/TEL partner gene, ARG (ABL-related gene or ABL2), identified in an AML-M3 cell line with a t(1;12)(q25;p13) translocation.
    Iijima Y; Ito T; Oikawa T; Eguchi M; Eguchi-Ishimae M; Kamada N; Kishi K; Asano S; Sakaki Y; Sato Y
    Blood; 2000 Mar; 95(6):2126-31. PubMed ID: 10706884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemopoietic transformation by the TEL/ABL oncogene.
    Hannemann JR; McManus DM; Kabarowski JH; Wiedemann LM
    Br J Haematol; 1998 Jul; 102(2):475-85. PubMed ID: 9695962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal transduction and cellular functions of the TEL/ARG oncoprotein.
    Okuda K; Oda A; Sato Y; Nakayama A; Fujita H; Sonoda Y; Griffin JD
    Leukemia; 2005 Apr; 19(4):603-10. PubMed ID: 15729383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation of Ba/F3 cells and Rat-1 cells by ETV6/ARG.
    Iijima Y; Okuda K; Tojo A; Tri NK; Setoyama M; Sakaki Y; Asano S; Tokunaga K; Kruh GD; Sato Y
    Oncogene; 2002 Jun; 21(28):4374-83. PubMed ID: 12080468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TEL/ARG leukemia oncogene promotes viability and hyperresponsiveness to hematopoietic growth factors.
    Okuda K; Sato Y; Sonoda Y; Griffin JD
    Int J Hematol; 2004 Feb; 79(2):138-46. PubMed ID: 15005341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MN1-TEL myeloid oncoprotein expressed in multipotent progenitors perturbs both myeloid and lymphoid growth and causes T-lymphoid tumors in mice.
    Kawagoe H; Grosveld GC
    Blood; 2005 Dec; 106(13):4278-86. PubMed ID: 16081688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia.
    Cuenco GM; Ren R
    Oncogene; 2001 Dec; 20(57):8236-48. PubMed ID: 11781838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional interaction between the c-Abl and Arg protein-tyrosine kinases in the oxidative stress response.
    Cao C; Leng Y; Li C; Kufe D
    J Biol Chem; 2003 Apr; 278(15):12961-7. PubMed ID: 12569093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tyrosine kinase abl-related gene ARG is fused to ETV6 in an AML-M4Eo patient with a t(1;12)(q25;p13): molecular cloning of both reciprocal transcripts.
    Cazzaniga G; Tosi S; Aloisi A; Giudici G; Daniotti M; Pioltelli P; Kearney L; Biondi A
    Blood; 1999 Dec; 94(12):4370-3. PubMed ID: 10590083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
    Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
    Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-receptor tyrosine kinases c-Abl and Arg regulate the activity of C/EBPbeta.
    Li X; Liu X; Wang G; Zhu X; Qu X; Li X; Yang Y; Peng L; Li C; Li P; Huang W; Ma Q; Cao C
    J Mol Biol; 2009 Aug; 391(4):729-43. PubMed ID: 19563810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.